These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 28988562)
1. Epidemiology of hepatitis C virus among hemodialysis patients in the Middle East and North Africa: systematic syntheses, meta-analyses, and meta-regressions. Harfouche M; Chemaitelly H; Mahmud S; Chaabna K; Kouyoumjian SP; Al Kanaani Z; Abu-Raddad LJ Epidemiol Infect; 2017 Nov; 145(15):3243-3263. PubMed ID: 28988562 [TBL] [Abstract][Full Text] [Related]
2. Systematic overview of hepatitis C infection in the Middle East and North Africa. Chaabna K; Cheema S; Abraham A; Alrouh H; Lowenfels AB; Maisonneuve P; Mamtani R World J Gastroenterol; 2018 Jul; 24(27):3038-3054. PubMed ID: 30038471 [TBL] [Abstract][Full Text] [Related]
3. The status of hepatitis C virus infection among people who inject drugs in the Middle East and North Africa. Mahmud S; Mumtaz GR; Chemaitelly H; Al Kanaani Z; Kouyoumjian SP; Hermez JG; Abu-Raddad LJ Addiction; 2020 Jul; 115(7):1244-1262. PubMed ID: 32009283 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus viremic rate in the Middle East and North Africa: Systematic synthesis, meta-analyses, and meta-regressions. Harfouche M; Chemaitelly H; Kouyoumjian SP; Mahmud S; Chaabna K; Al-Kanaani Z; Abu-Raddad LJ PLoS One; 2017; 12(10):e0187177. PubMed ID: 29088252 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus genotypes in the Middle East and North Africa: Distribution, diversity, and patterns. Mahmud S; Al-Kanaani Z; Chemaitelly H; Chaabna K; Kouyoumjian SP; Abu-Raddad LJ J Med Virol; 2018 Jan; 90(1):131-141. PubMed ID: 28842995 [TBL] [Abstract][Full Text] [Related]
6. Characterizing trends and associations for hepatitis C virus antibody prevalence in the Middle East and North Africa: meta-regression analyses. Mahmud S; Chemaitelly H; Alaama AS; Hermez JG; Abu-Raddad LJ Sci Rep; 2022 Nov; 12(1):20637. PubMed ID: 36450850 [TBL] [Abstract][Full Text] [Related]
7. Protocol for a systematic review and meta-analysis of hepatitis C virus (HCV) prevalence and incidence in the Horn of Africa sub-region of the Middle East and North Africa. Chaabna K; Mohamoud YA; Chemaitelly H; Mumtaz GR; Abu-Raddad LJ Syst Rev; 2014 Dec; 3():146. PubMed ID: 25516265 [TBL] [Abstract][Full Text] [Related]
8. Key associations for hepatitis C virus genotypes in the Middle East and North Africa. Mahmud S; Chemaitelly HS; Kouyoumjian SP; Al Kanaani Z; Abu-Raddad LJ J Med Virol; 2020 Mar; 92(3):386-393. PubMed ID: 31663611 [TBL] [Abstract][Full Text] [Related]
9. The epidemiology of hepatitis C virus in the Maghreb region: systematic review and meta-analyses. Fadlalla FA; Mohamoud YA; Mumtaz GR; Abu-Raddad LJ PLoS One; 2015; 10(3):e0121873. PubMed ID: 25803848 [TBL] [Abstract][Full Text] [Related]
10. Individual-level key associations and modes of exposure for hepatitis C virus infection in the Middle East and North Africa: a systematic synthesis. Mahmud S; Kouyoumjian SP; Al Kanaani Z; Chemaitelly H; Abu-Raddad LJ Ann Epidemiol; 2018 Jul; 28(7):452-461. PubMed ID: 29661680 [TBL] [Abstract][Full Text] [Related]
11. The Epidemiology of Hepatitis C Virus in the Fertile Crescent: Systematic Review and Meta-Analysis. Chemaitelly H; Chaabna K; Abu-Raddad LJ PLoS One; 2015; 10(8):e0135281. PubMed ID: 26296200 [TBL] [Abstract][Full Text] [Related]
12. Status of HIV and hepatitis C virus infections among prisoners in the Middle East and North Africa: review and synthesis. Heijnen M; Mumtaz GR; Abu-Raddad LJ J Int AIDS Soc; 2016; 19(1):20873. PubMed ID: 27237131 [TBL] [Abstract][Full Text] [Related]
13. Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker. Mohamoud YA; Miller FD; Abu-Raddad LJ World J Gastroenterol; 2014 Sep; 20(36):12734-52. PubMed ID: 25278675 [TBL] [Abstract][Full Text] [Related]
14. Sub-genotypes of hepatitis C virus in the Middle East and North Africa: Patterns of distribution and temporal changes. Athamneh RY; Abudalo R; Sallam M; Alqudah A; Alquran H; Amawi KF; Abu-Harirah HA Infect Genet Evol; 2023 Apr; 109():105412. PubMed ID: 36791585 [TBL] [Abstract][Full Text] [Related]
15. The prevalence and associated factors of hepatitis B and C virus in hemodialysis patients in Africa: A systematic review and meta-analysis. Adane T; Getawa S PLoS One; 2021; 16(6):e0251570. PubMed ID: 34157037 [TBL] [Abstract][Full Text] [Related]
16. Using hepatitis C prevalence to estimate HIV epidemic potential among people who inject drugs in the Middle East and North Africa. Mumtaz GR; Weiss HA; Vickerman P; Larke N; Abu-Raddad LJ AIDS; 2015 Aug; 29(13):1701-10. PubMed ID: 26372281 [TBL] [Abstract][Full Text] [Related]
17. Prevalence, incidence, and risk factors for hepatitis C virus infection in hemodialysis patients. Jadoul M; Bieber BA; Martin P; Akiba T; Nwankwo C; Arduino JM; Goodkin DA; Pisoni RL Kidney Int; 2019 Apr; 95(4):939-947. PubMed ID: 30904068 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of hepatitis C virus infection among hemodialysis patients in the Middle-East: A systematic review and meta-analysis. Ashkani-Esfahani S; Alavian SM; Salehi-Marzijarani M World J Gastroenterol; 2017 Jan; 23(1):151-166. PubMed ID: 28104991 [TBL] [Abstract][Full Text] [Related]
20. Incidence and patterns of hepatitis C virus seroconversion in a cohort of hemodialysis patients. Sypsa V; Psichogiou M; Katsoulidou A; Skoutelis G; Moutafis S; Hadjiconstantinou V; Kakavas J; Kalapothaki V; Boletis J; Hatzakis A Am J Kidney Dis; 2005 Feb; 45(2):334-43. PubMed ID: 15685512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]